Terasaki Talks: Dr. Md Nurunnabi

Bioengineered Oral Medicine to Treat Obesity and Diabetes


Obesity is considered a strong factor in many chronic diseases, including heart disease, cancer, and diabetes. Along with genetics, consumption of excessive fat and cholesterol-rich food are the primary causes of obesity. However, despite of an alarming emergency there has been little progress made developing medications for controlling obesity, conveniently and effectively.

In this seminar, I will talk about various approaches of treating type 2 diabetes and obesity using oral formulations such as ionic liquid that prevents the fat from penetrating through the intestinal membrane. In our recent study we have observed that a regular oral dose of ionic liquid may result less body weight gain compared with the control/untreated rats. On the same line, we have developed an oral formulation to deliver DNA encoded-glucagon like peptide-1 to treat T2D, shows significant reduction of body weight and blood glucose level in rat model.


Md Nurunnabi is an assistant professor of Pharmaceutics at UT El Paso. His laboratory focuses on biomaterials and drug delivery research. Prior to starting his independent position, he was a Postdoctoral fellow with Prof. Samir Mitragotri at Wyss Institute of Harvard University. He completed MS and PhD in Bioengineering from Korea National University of Transportation, and BS in Pharmacy from University of Development Alternative and a shot Postdoctoral training at Chungnam National University in Korea before moving to USA in 2016. He has published 50 peer-reviewed research articles, 8 book chapters, edited 2 books for Elsevier. He is an inventor of 10 patents that resulted several startups in South Korea and USA. For details-

Event Information

Event Date 08-12-2020 8:00 am
Event End Date 08-12-2020 9:00 am
Registration Start Date 07-02-2020
Cut off date 08-12-2020 8:15 am

We are no longer accepting registration for this event

Our Locations

Follow Us